Similar articles for PMID: 21336958

Year	Number of Results
1994	2
1995	1
1996	1
1998	1
1999	3
2000	4
2001	3
2002	3
2003	4
2004	3
2005	2
2006	6
2007	5
2008	3
2009	2
2010	6
2011	8
2012	4
2013	9
2014	4
2015	6
2016	6
2017	6
2018	6
2019	2
2020	3
2021	4
2022	1
2023	1
2024	0

1

Should pathologists continue to use the current pT2 substaging system for reporting of radical prostatectomy specimens?

Billis A, Meirelles LL, Freitas LL, Magna LA, Reis LO, Ferreira U. Billis A, et al. Int Urol Nephrol. 2011 Sep;43(3):707-14. doi: 10.1007/s11255-011-9906-0. Epub 2011 Feb 20. Int Urol Nephrol. 2011. PMID: 21336958

2

Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.

Freedland SJ, Presti JC Jr, Terris MK, Kane CJ, Aronson WJ, Dorey F, Amling CL; SEARCH Database Study Group. Freedland SJ, et al. J Urol. 2003 Jun;169(6):2129-35. doi: 10.1097/01.ju.0000065763.21602.14. J Urol. 2003. PMID: 12771734

3

[The 1992 TNM classification of T2 prostate cancer predicts pathologic stage and prognosis better than the revised 1997 classification].

Koh H, Maru N, Muramoto M, Wheeler TM, Scardino PT, Ohori M. Koh H, et al. Nihon Hinyokika Gakkai Zasshi. 2002 Jul;93(5):595-601. doi: 10.5980/jpnjurol1989.93.595. Nihon Hinyokika Gakkai Zasshi. 2002. PMID: 12174634 Free article. Japanese.

4

The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system.

van Oort IM, Witjes JA, Kok DE, Kiemeney LA, Hulsbergen-Van De Kaa CA. van Oort IM, et al. BJU Int. 2008 Aug;102(4):438-41. doi: 10.1111/j.1464-410X.2008.07611.x. Epub 2008 Mar 11. BJU Int. 2008. PMID: 18336608

5

Percent tumor volume vs American Joint Committee on Cancer staging system subclassification for predicting biochemical recurrence in patients with pathologic T2 prostate cancer.

Choi SY, Chi BH, Lim B, Kyung YS, You D, Jeong IG, Song C, Hong JH, Ahn H, Kim CS. Choi SY, et al. J Cancer Res Clin Oncol. 2020 Feb;146(2):537-543. doi: 10.1007/s00432-019-03085-w. Epub 2020 Jan 8. J Cancer Res Clin Oncol. 2020. PMID: 31915914

6

Various morphometric measurements of cancer extent on needle prostatic biopsies: which is predictive of pathologic stage and biochemical recurrence following radical prostatectomy?

Quintal MM, Meirelles LR, Freitas LL, Magna LA, Ferreira U, Billis A. Quintal MM, et al. Int Urol Nephrol. 2011 Sep;43(3):697-705. doi: 10.1007/s11255-011-9901-5. Epub 2011 Feb 22. Int Urol Nephrol. 2011. PMID: 21340462

7

Modification of the pT2 substage classification in prostate adenocarcinoma.

Ettel M, Kong M, Lee P, Zhou M, Melamed J, Deng FM. Ettel M, et al. Hum Pathol. 2016 Oct;56:57-63. doi: 10.1016/j.humpath.2016.05.016. Epub 2016 May 29. Hum Pathol. 2016. PMID: 27251951

8

Outcome evaluation of the 1997 American Joint Committee on Cancer staging system for prostate carcinoma treated by radiation therapy.

Iyer RV, Hanlon AL, Pinover WH, Hanks GE. Iyer RV, et al. Cancer. 1999 Apr 15;85(8):1816-21. doi: 10.1002/(sici)1097-0142(19990415)85:8<1816::aid-cncr23>3.0.co;2-u. Cancer. 1999. PMID: 10223577

9

Are prostate carcinoma clinical stages T1c and T2 similar?

Billis A, Magna LA, Watanabe IC, Costa MV, Telles GH, Ferreira U. Billis A, et al. Int Braz J Urol. 2006 Mar-Apr;32(2):165-71. doi: 10.1590/s1677-55382006000200006. Int Braz J Urol. 2006. PMID: 16650293 Free article.

10

Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b.

Freedland SJ, Partin AW, Epstein JI, Walsh PC. Freedland SJ, et al. Cancer. 2004 Apr 15;100(8):1646-9. doi: 10.1002/cncr.20145. Cancer. 2004. PMID: 15073852 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year